Found: 96
Select item for more details and to access through your institution.
5q21 deletion is often heterogeneous in prostate cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2019, v. 58, n. 8, p. 509, doi. 10.1002/gcc.22730
- By:
- Publication type:
- Article
13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2018, v. 57, n. 10, p. 504, doi. 10.1002/gcc.22645
- By:
- Publication type:
- Article
Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice.
- Published in:
- Genes, Chromosomes & Cancer, 2014, v. 53, n. 3, p. 228, doi. 10.1002/gcc.22130
- By:
- Publication type:
- Article
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion.
- Published in:
- Molecular Medicine, 2020, v. 26, n. 1, p. 1, doi. 10.1186/s10020-020-00148-4
- By:
- Publication type:
- Article
High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
- Published in:
- BJU International, 2017, v. 120, n. 3, p. 365, doi. 10.1111/bju.13840
- By:
- Publication type:
- Article
Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy.
- Published in:
- BJU International, 2017, v. 119, n. 6, p. 854, doi. 10.1111/bju.13782
- By:
- Publication type:
- Article
Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.
- Published in:
- International Journal of Surgical Pathology, 2023, v. 31, n. 6, p. 927, doi. 10.1177/10668969221117243
- By:
- Publication type:
- Article
Author Correction: Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-30975-9
- By:
- Publication type:
- Article
SNW1 is a prognostic biomarker in prostate cancer.
- Published in:
- Diagnostic Pathology, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13000-019-0810-8
- By:
- Publication type:
- Article
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 286, doi. 10.3390/ijms18020286
- By:
- Publication type:
- Article
VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 4, p. 8591, doi. 10.3390/ijms16048591
- By:
- Publication type:
- Article
Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 4, p. 1637, doi. 10.3892/ijo.2015.2855
- By:
- Publication type:
- Article
High BCAR1 expression is linked to adverse tumour features and early PSA recurrence in ERG negative prostate cancers.
- Published in:
- Canadian Journal of Pathology, 2016, v. 8, p. 14
- By:
- Publication type:
- Article
HDAC3 overexpression is an independent predictor of poor prognosis and is associated with genomic instability in prostate cancer.
- Published in:
- Canadian Journal of Pathology, 2016, v. 8, p. 14
- By:
- Publication type:
- Article
Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 481, n. 6, p. 945, doi. 10.1007/s00428-022-03394-5
- By:
- Publication type:
- Article
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 480, n. 2, p. 433, doi. 10.1007/s00428-021-03204-4
- By:
- Publication type:
- Article
Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2020, v. 477, n. 5, p. 625, doi. 10.1007/s00428-020-02834-4
- By:
- Publication type:
- Article
Expression of the immune checkpoint receptor TIGIT in seminoma.
- Published in:
- Oncology Letters, 2019, v. 18, n. 2, p. 1497, doi. 10.3892/ol.2019.10428
- By:
- Publication type:
- Article
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases.
- Published in:
- Oncology Letters, 2018, v. 16, n. 5, p. 6238, doi. 10.3892/ol.2018.9417
- By:
- Publication type:
- Article
Pattern of MUC6 expression across 119 different tumor types: A tissue microarray study on 15 412 tumors.
- Published in:
- Pathology International, 2023, v. 73, n. 7, p. 281, doi. 10.1111/pin.13322
- By:
- Publication type:
- Article
Deletion of 3p13 is a late event linked to progression of <em>TMPRSS2:ERG</em> fusion prostate cancer.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 5909, doi. 10.2147/CMAR.S172637
- By:
- Publication type:
- Article
CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas.
- Published in:
- PLoS ONE, 2023, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0287528
- By:
- Publication type:
- Article
Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 1, p. 129, doi. 10.1002/1878-0261.12597
- By:
- Publication type:
- Article
High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.
- Published in:
- Molecular Oncology, 2013, v. 7, n. 6, p. 1001, doi. 10.1016/j.molonc.2013.07.009
- By:
- Publication type:
- Article
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors.
- Published in:
- Journal of Pathology: Clinical Research, 2021, v. 7, n. 6, p. 577, doi. 10.1002/cjp2.237
- By:
- Publication type:
- Article
High B7‐H3 expression is linked to increased risk of prostate cancer progression.
- Published in:
- Pathology International, 2020, v. 70, n. 10, p. 733, doi. 10.1111/pin.12999
- By:
- Publication type:
- Article
Upregulation of PTTG1 is associated with poor prognosis in prostate cancer.
- Published in:
- Pathology International, 2020, v. 70, n. 7, p. 441, doi. 10.1111/pin.12938
- By:
- Publication type:
- Article
Subcellular Compartmentalization of Survivin is Associated with Biological Aggressiveness and Prognosis in Prostate Cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60064-9
- By:
- Publication type:
- Article
Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 6, p. 1202, doi. 10.3390/diagnostics13061202
- By:
- Publication type:
- Article
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 10, p. 2516, doi. 10.3390/diagnostics12102516
- By:
- Publication type:
- Article
Loss of Somatostatin Receptor Subtype 2 in Prostate Cancer Is Linked to an Aggressive Cancer Phenotype, High Tumor Cell Proliferation and Predicts Early Metastatic and Biochemical Relapse.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0100469
- By:
- Publication type:
- Article
No Detection of XMRV in Blood Samples and Tissue Sections from Prostate Cancer Patients in Northern Europe.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0025592
- By:
- Publication type:
- Article
Automated Ki‐67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 1, p. 5, doi. 10.1002/path.6057
- By:
- Publication type:
- Article
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.
- Published in:
- Journal of Pathology, 2013, v. 231, n. 1, p. 130, doi. 10.1002/path.4223
- By:
- Publication type:
- Article
Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
- Published in:
- Molecular Medicine, 2021, v. 27, n. 1, p. 1, doi. 10.1186/s10020-021-00274-7
- By:
- Publication type:
- Article
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancer.
- Published in:
- World Journal of Urology, 2018, v. 36, n. 6, p. 877, doi. 10.1007/s00345-018-2225-7
- By:
- Publication type:
- Article
βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinoma.
- Published in:
- World Journal of Urology, 2015, v. 33, n. 10, p. 1561, doi. 10.1007/s00345-014-1463-6
- By:
- Publication type:
- Article
Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.
- Published in:
- World Journal of Urology, 2013, v. 31, n. 4, p. 847, doi. 10.1007/s00345-011-0783-z
- By:
- Publication type:
- Article
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer.
- Published in:
- Scientific Reports, 2017, v. 7, n. 1, p. 1, doi. 10.1038/s41598-017-02279-x
- By:
- Publication type:
- Article
Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
- Published in:
- BJU International, 2011, v. 107, n. 10, p. 1668, doi. 10.1111/j.1464-410X.2010.09562.x
- By:
- Publication type:
- Article
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
- Published in:
- Carcinogenesis, 2017, v. 38, n. 1, p. 19, doi. 10.1093/carcin/bgw116
- By:
- Publication type:
- Article
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters.
- Published in:
- Carcinogenesis, 2015, v. 36, n. 11, p. 1333, doi. 10.1093/carcin/bgv137
- By:
- Publication type:
- Article
Random forest-based modelling to detect biomarkers for prostate cancer progression.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0736-8
- By:
- Publication type:
- Article
Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 5, p. 1268, doi. 10.1002/cncr.26436
- By:
- Publication type:
- Article
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer.
- Published in:
- Disease Markers, 2020, p. 1, doi. 10.1155/2020/7050146
- By:
- Publication type:
- Article
Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer.
- Published in:
- Disease Markers, 2020, p. 1, doi. 10.1155/2020/7050146
- By:
- Publication type:
- Article
Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer.
- Published in:
- Disease Markers, 2019, p. 1, doi. 10.1155/2019/5160565
- By:
- Publication type:
- Article